Physician profile
Mohammad Aslam
NPI 1427024728
$3,951.92
in general payments reported to CMS, 2019-2025
43 companies · none reported in 2025
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $1,452 · 2020: $1,177 · 2021: $993 · 2022: $330.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $506.52 | 2019-2021 | |
| Amgen INC. | $389.26 | 2019-2022 | |
| Avanir Pharmaceuticals, INC. | $204.33 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $182.75 | 2019-2022 | |
| Sk Life Science, INC. | $166.49 | 2020-2021 | |
| Genzyme Corporation | $157.11 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $137.99 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $125.01 | 2019-2022 | |
| Novartis Gene Therapies, INC. (Fka Avexis, INC.) | $120.00 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $118.49 | 2019-2021 | |
| Pfizer INC. | $116.37 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $115.05 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $114.98 | 2019 | |
| Daiichi Sankyo INC. | $111.25 | 2019 | |
| Abbvie INC. | $110.33 | 2021-2022 |
Show all 42 companies
1 company reported research payments only; those appear in the research section below.
Research and ownership
$125.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Aslam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.